Bain

Bain Capital Life Sciences (BCLS) is a leading private investment firm focused on the global biopharmaceutical, medical device, diagnostic, and life science tool sectors. Founded in 2016 as a dedicated unit of Bain Capital, the firm leverages deep clinical and operational expertise to invest across the full life cycle of companies, from early-stage startups to mature commercial enterprises. BCLS is particularly known for its "company creation" model, where it partners with major pharmaceutical companies like Pfizer and Bristol Myers Squibb to spin out promising internal assets into independent, well-funded biotechs such as Cerevel Therapeutics, SpringWorks Therapeutics, and Beeline Medicines. With over $6.7 billion in total capital raised across four dedicated funds, the firm plays a pivotal role in advancing innovative therapies for unmet medical needs in immunology, oncology, and metabolic diseases.